Glo Science, Inc.   Report issue

For profit
Founded: New York NY United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2015
NCT03196648
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Glo Science, Inc.

Active Ingredients

Drugs in Other Trials (3)

hydrogen peroxide (1 trial)

monofluorophosphate (1 trial)

sodium fluoride (18F) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3